Quarter
Charts

Aveanna Healthcare Holdings Inc.

AVAH

CIK 0001832332 · Quarterly mode · latest period FY2026 (Q4) (ending 2026-01-03) · sourced from SEC EDGAR

At a glance · FY2026 (Q4)

Revenue
$662M
↑+27.4% +$143Mvs FY2024 (Q4)
Operating Income
$71M
↑+55.2% +$25Mvs FY2024 (Q4)
Net Income
$39M
↑+45.7% +$12Mvs FY2024 (Q4)
Gross Profit
$213M
↑+24.2% +$42Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Strong
67/100
  • Profitability
    72ROIC 19.3% (10% = solid, 20%+ = moat)
  • Liquidity
    41Current Ratio 1.32 (above 1.5 = solid)
  • Leverage
    0D/E 6.68 (under 0.5 = conservative)
  • Efficiency
    86Asset Turnover 1.32x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +27.4% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin 10.7% · trend +3.7pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project AVAH's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$10.07
Total enterprise IV
$2.17B
Diluted shares
0.21B
Terminal PV
$1.57B (72% of total)
Year-5 FCF
$185M
YearProjected FCFDiscounted PV
+1$136M$124M
+2$147M$121M
+3$159M$119M
+4$171M$117M
+5$185M$115M
Terminal$2.53B$1.57B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
—
investment in PP&E
Stock-based comp (TTM)
$25M
non-cash dilution

Balance sheet · 2026-01-03

latest filed snapshot
Total assets
$2.01B
everything owned
Total liabilities
$1.82B
everything owed
Stockholders' equity
$194M
shareholder claim
Net debt
$1.11B
LT debt minus cash

Recent performance · 26 quarters

Revenue↑+27.4% +$143M
$662M
Net Income↑+512.6% +$150M
$179M
Free Cash Flow↑+270.9% +$36M
$50M
Operating Margin↑+1.9pts
10.7%

Drill down

AVAH Sankey

See Aveanna Healthcare Holdings Inc.'s revenue flow into every line item of the income statement and balance sheet — every dollar accounted for, with prior-period comparison.

Open Sankey

AVAH Charts

26 quarters of historical line items — Income, Cash Flow, Balance Sheet, plus margins. Click any chart for the trend dialog.

Open Charts

AVAH Key Metrics

EPS, BVPS, FCF/Share, ROE, ROA, ROIC, D/E, Current Ratio, Quick Ratio, Asset Turnover — 10 CFA-grade fundamentals derived from EDGAR data.

Open Key Metrics